Key facts
- Emergency admissions for high blood pressure rose to 43,306 in 2025-26 from 24,481 in 2019-20, NHS England figures show.
- Hospital care episodes with a hypertension diagnosis were 31,582 for women and 23,317 for men in 2025-26, the analysis found.
- NHS England invited almost 3.8 million people for a health check in 2025-26; 1.3 million took up the offer.
- Helen Williams of NHS England said high blood pressure is a major risk factor for heart attacks, strokes, heart failure and chronic kidney disease.
- Community pharmacies carried out more than 3.3 million checks in the 12 months to July 2026, identifying more than 375,000 people needing monitoring.
Emergency hospital admissions for high blood pressure in England rose 77% to 43,306 in 2025-26 from 24,481 in 2019-20, according to NHS England figures reported by the Healthcare Leader on November 21, 2026.
The analysis found a third more hospital care episodes with a hypertension diagnosis among women, at 31,582, than among men, at 23,317, in 2025-26. NHS England urged eligible adults aged 40-74 who have not attended a free NHS health check in the past five years to take one up. In 2025-26, almost 3.8 million people were invited for a check and 1.3 million took up the offer.
Helen Williams, national clinical director for cardiovascular disease prevention at NHS England, said: "The increase of people needing emergency care due to high blood pressure is alarming." She said high blood pressure is a major risk factor for heart attacks, strokes, heart failure and chronic kidney disease and can in many cases be detected and treated earlier.
NHS England said the Cardiovascular Disease Modern Service Framework sets out plans to improve early detection of cardiovascular risk factors, reduce health inequalities and improve access to treatment through community-based prevention and digital tools. In the 12 months to July 2026, community pharmacies in England carried out more than 3.3 million checks through the Hypertension Case Finding Service, identifying more than 375,000 people requiring additional monitoring through pharmacies for analysis by a GP.
